Flagship explainer

How NEUROCRINE BIOSCIENCES INC makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$2.9B · 100%Cost of revenue$52.1M · 2%Gross profit$2.8B · 98%Operating income$619M · 22%Income before tax$705M · 25%Income tax$227M · 8%Net income$479M · 17%As of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$2.9B100%
Cost of revenue$52.1M2%
$2.8B98%
$619M22%
Income before tax$705M25%
Income tax$227M8%
$479M17%
Source: · event Dec 31, 2025 · retrieved Sep 19, 2026 · annual-row source set
Embed this chart

View the full NEUROCRINE BIOSCIENCES INC analysis at Buy Like Buffett